Physician profile
Nicole Smith
NPI 1932712288
$602.82
in general payments reported to CMS, 2019-2025
12 companies · $294 in 2025
The $294 reported for 2025 was more than what 89% of Advanced Practice Midwife providers received nationally (typical 2025 total: $70.87).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $124 · 2024: $185 · 2025: $294.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $603.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $602.82 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Acadia Pharmaceuticals INC | $142.11 | 2024-2025 | Nuplazid |
| Teva Pharmaceuticals USA, INC. | $136.85 | 2025 | Austedo Xr |
| Sage Therapeutics, LLC | $100.16 | 2023 | |
| Mayne Pharma Commercial LLC | $53.33 | 2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $29.36 | 2025 | |
| Organon LLC | $29.16 | 2024 | |
| Shield Therapeutics INC | $26.47 | 2024 | |
| Coopersurgical, INC. | $23.63 | 2023 | Paragard T 380a |
| Axonics, INC. | $17.98 | 2024 | Axonics |
| Optumhealth Care Solutions, LLC | $15.51 | 2025 | Vivify Health Care Team Portal 001, Eitan Medical |
| Astellas Pharma US INC | $14.98 | 2025 | Veozah |
| Pfizer INC. | $13.28 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nicole Smith listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.